Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy

Purpose: To evaluate the effect of spironolactone on chronic central serous chorioretinopathy (CSC). Methods: In this prospective interventional case series, patients with chronic cSc were treated with spironolactone (25 mg daily) for at least 6 weeks. If the subretinal fluid (SRF) had not completel...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Khalil Ghasemi Falavarjani, Anahita Amirsardari, Abbas Habibi, Acieh Eshaghi, Shohreh Bakhti, Kaveh Abri Aghdam
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Knowledge E 2017-01-01
סדרה:	Journal of Ophthalmic & Vision Research
נושאים:	Central Serous Chorioretinopathy; Optical Coherence Tomography; Spironolactone; Subretinal Fluid
גישה מקוונת:	http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=3;spage=281;epage=289;aulast=Falavarjani
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!